Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Hungerford

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The British Journal of Ophthalmology|January 1, 1993
Relationship of regression pattern to recurrence in retinoblastomaA D Singh, D Garway-Heath, S Love, et al.
Clinical Nuclear Medicine|November 1, 1990
Radioimmunoscintigraphy of orbital metastases from ovarian carcinomaJ Bomanji, J Glaholm, J L Hungerford, et al.
The British Journal of Ophthalmology|May 19, 2006
Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?D S Gombos, P A Cauchi, J L Hungerford, et al.
Anti-Cancer Drugs|December 13, 1997
The ex vivo chemosensitivity profile of choroidal melanomaN Myatt, I A Cree, C M Kurbacher, et al.
British Journal of Cancer|July 1, 1995
The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reactionA J Foss, M J Guille, N L Occleston, et al.
Ophthalmology|January 27, 1998
Treatment of retinoblastoma vitreous base seedingS A Madreperla, J L Hungerford, D Doughty, et al.
The British Journal of Ophthalmology|September 1, 1987
Characterisation of ocular melanoma with cutaneous melanoma antibodiesJ Bomanji, A Garner, J Prasad, et al.
Lancet (London, England)|July 23, 1983
Ocular toxicity of high-dose intravenous desferrioxamineS C Davies, R E Marcus, J L Hungerford, et al.
British Journal of Cancer|June 5, 2003
Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomasS C Edmunds, I A Cree, F Dí Nícolantonío, et al.
The Journal of Pathology|December 13, 2000
Abnormalities of the transforming growth factor-beta pathway in ocular melanomaN Myatt, P Aristodemou, M H Neale, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The British Journal of Ophthalmology|January 1, 1993
Relationship of regression pattern to recurrence in retinoblastomaA D Singh, D Garway-Heath, S Love, et al.
Clinical Nuclear Medicine|November 1, 1990
Radioimmunoscintigraphy of orbital metastases from ovarian carcinomaJ Bomanji, J Glaholm, J L Hungerford, et al.
The British Journal of Ophthalmology|May 19, 2006
Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?D S Gombos, P A Cauchi, J L Hungerford, et al.
Anti-Cancer Drugs|December 13, 1997
The ex vivo chemosensitivity profile of choroidal melanomaN Myatt, I A Cree, C M Kurbacher, et al.
British Journal of Cancer|July 1, 1995
The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reactionA J Foss, M J Guille, N L Occleston, et al.
Ophthalmology|January 27, 1998
Treatment of retinoblastoma vitreous base seedingS A Madreperla, J L Hungerford, D Doughty, et al.
The British Journal of Ophthalmology|September 1, 1987
Characterisation of ocular melanoma with cutaneous melanoma antibodiesJ Bomanji, A Garner, J Prasad, et al.
Lancet (London, England)|July 23, 1983
Ocular toxicity of high-dose intravenous desferrioxamineS C Davies, R E Marcus, J L Hungerford, et al.
British Journal of Cancer|June 5, 2003
Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomasS C Edmunds, I A Cree, F Dí Nícolantonío, et al.
The Journal of Pathology|December 13, 2000
Abnormalities of the transforming growth factor-beta pathway in ocular melanomaN Myatt, P Aristodemou, M H Neale, et al.
Pageof 10